Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin

ClinicalTrials.gov ID: NCT01046110

Public ClinicalTrials.gov record NCT01046110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Trial Comparing Efficacy and Safety of NN1250 With Sitagliptin in Insulin Naive Subjects With Type 2 Diabetes (BEGIN™ : EARLY)

Study identification

NCT ID
NCT01046110
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
458 participants

Conditions and interventions

Interventions

  • insulin degludec Drug
  • sitagliptin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2009
Primary completion
Oct 31, 2010
Completion
Oct 31, 2010
Last update posted
Mar 2, 2017

2010

United States locations

U.S. sites
57
U.S. states
24
U.S. cities
51
Facility City State ZIP Site status
Novo Nordisk Investigational Site Huntsville Alabama 35801
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Greenbrae California 94904
Novo Nordisk Investigational Site La Jolla California 92037
Novo Nordisk Investigational Site Long Beach California 90806
Novo Nordisk Investigational Site Mission Hills California 91345
Novo Nordisk Investigational Site Palm Springs California 92262
Novo Nordisk Investigational Site Torrance California 90504
Novo Nordisk Investigational Site Walnut Creek California 94598-3347
Novo Nordisk Investigational Site Denver Colorado 80239-3133
Novo Nordisk Investigational Site Clearwater Florida 33765
Novo Nordisk Investigational Site Inverness Florida 34452
Novo Nordisk Investigational Site Kissimmee Florida 34741
Novo Nordisk Investigational Site Miami Florida 33125-1655
Novo Nordisk Investigational Site Miami Florida 33135
Novo Nordisk Investigational Site Miami Florida 33186
Novo Nordisk Investigational Site Ocala Florida 34471
Novo Nordisk Investigational Site Ponte Vedra Florida 32081
Novo Nordisk Investigational Site Tampa Florida 33603
Novo Nordisk Investigational Site Columbus Georgia 31904
Novo Nordisk Investigational Site Decatur Georgia 30033
Novo Nordisk Investigational Site Dunwoody Georgia 30338
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Chicago Illinois 60611
Novo Nordisk Investigational Site Chicago Illinois 60624
Novo Nordisk Investigational Site Springfield Illinois 62711
Novo Nordisk Investigational Site Huntington Indiana 46750-1404
Novo Nordisk Investigational Site Council Bluffs Iowa 51501
Novo Nordisk Investigational Site Des Moines Iowa 50314-2610
Novo Nordisk Investigational Site Paducah Kentucky 42003
Novo Nordisk Investigational Site Metairie Louisiana 70002
Novo Nordisk Investigational Site Brockton Massachusetts 02301
Novo Nordisk Investigational Site Livonia Michigan 48152-3501
Novo Nordisk Investigational Site Troy Michigan 48085-5524
Novo Nordisk Investigational Site Saint Paul Minnesota 55108
Novo Nordisk Investigational Site Jackson Mississippi 39216
Novo Nordisk Investigational Site Albuquerque New Mexico 87108
Novo Nordisk Investigational Site Albuquerque New Mexico 87131
Novo Nordisk Investigational Site New Hyde Park New York 11042
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Durham North Carolina 27710
Novo Nordisk Investigational Site Greenville North Carolina 27834-5784
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15224-2215
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15241
Novo Nordisk Investigational Site Charleston South Carolina 29401
Novo Nordisk Investigational Site Murrells Inlet South Carolina 29576
Novo Nordisk Investigational Site Corpus Christi Texas 78404
Novo Nordisk Investigational Site El Paso Texas 79905-2709
Novo Nordisk Investigational Site El Paso Texas 79912
Novo Nordisk Investigational Site Houston Texas 77070
Novo Nordisk Investigational Site Sugar Land Texas 77478
Novo Nordisk Investigational Site Tomball Texas 77375
Novo Nordisk Investigational Site Salt Lake City Utah 84107
Novo Nordisk Investigational Site Virginia Beach Virginia 23454
Novo Nordisk Investigational Site Spokane Washington 99208

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01046110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2017 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01046110 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →